CN112137904A - 一种幻彩水光肌底精华液及其制备方法 - Google Patents
一种幻彩水光肌底精华液及其制备方法 Download PDFInfo
- Publication number
- CN112137904A CN112137904A CN202011085102.XA CN202011085102A CN112137904A CN 112137904 A CN112137904 A CN 112137904A CN 202011085102 A CN202011085102 A CN 202011085102A CN 112137904 A CN112137904 A CN 112137904A
- Authority
- CN
- China
- Prior art keywords
- extract
- percent
- essence
- skin
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 98
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 46
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 42
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 30
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 30
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 30
- 239000000047 product Substances 0.000 claims abstract description 25
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 18
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 14
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 14
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 14
- 240000007594 Oryza sativa Species 0.000 claims abstract description 14
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 14
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 14
- 230000004151 fermentation Effects 0.000 claims abstract description 14
- 239000000706 filtrate Substances 0.000 claims abstract description 14
- 229960003415 propylparaben Drugs 0.000 claims abstract description 14
- 235000009566 rice Nutrition 0.000 claims abstract description 14
- 239000012138 yeast extract Substances 0.000 claims abstract description 14
- 244000125300 Argania sideroxylon Species 0.000 claims abstract description 12
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims abstract description 12
- 229940051810 licorice root extract Drugs 0.000 claims abstract description 12
- 235000020725 licorice root extract Nutrition 0.000 claims abstract description 12
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims abstract description 11
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 10
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract description 10
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 10
- 229940084779 albizia julibrissin bark extract Drugs 0.000 claims abstract description 10
- 241000092665 Atractylodes macrocephala Species 0.000 claims abstract description 8
- 241001180873 Saposhnikovia divaricata Species 0.000 claims abstract description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 4
- 229960002216 methylparaben Drugs 0.000 claims abstract description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 22
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 18
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 13
- 235000011187 glycerol Nutrition 0.000 claims description 13
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 13
- 241000219357 Cactaceae Species 0.000 claims description 11
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 11
- 229940032094 squalane Drugs 0.000 claims description 11
- 235000016108 Argania sideroxylon Nutrition 0.000 claims description 10
- -1 polydimethylsiloxane Polymers 0.000 claims description 10
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 9
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 9
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 9
- 235000021355 Stearic acid Nutrition 0.000 claims description 9
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 9
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 9
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 claims description 9
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 9
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 9
- 229960005323 phenoxyethanol Drugs 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 229940057910 shea butter Drugs 0.000 claims description 9
- 229940084750 sophora flavescens root extract Drugs 0.000 claims description 9
- 229940114926 stearate Drugs 0.000 claims description 9
- 229960004274 stearic acid Drugs 0.000 claims description 9
- 239000008117 stearic acid Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 9
- XYCBMTYEYMEOOG-XYDYARRRSA-L N[C@@H](CCC(=O)[O-])C(=O)OCCCCCCCCCCCCCCCCCC.[Na+].[Na+].C(CCCCCCCCCCCCCCCCC)OC([C@@H](N)CCC(=O)[O-])=O Chemical compound N[C@@H](CCC(=O)[O-])C(=O)OCCCCCCCCCCCCCCCCCC.[Na+].[Na+].C(CCCCCCCCCCCCCCCCC)OC([C@@H](N)CCC(=O)[O-])=O XYCBMTYEYMEOOG-XYDYARRRSA-L 0.000 claims description 8
- 241000132012 Atractylodes Species 0.000 claims description 7
- 229920001202 Inulin Polymers 0.000 claims description 6
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- 238000003760 magnetic stirring Methods 0.000 claims description 6
- 229920000570 polyether Polymers 0.000 claims description 6
- 241000220433 Albizia Species 0.000 claims description 5
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 5
- 241001632409 Aralia elata Species 0.000 claims description 5
- 235000015888 Aralia elata Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 229930195210 Ophiopogon Natural products 0.000 claims description 3
- 244000248557 Ophiopogon japonicus Species 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 27
- 230000003405 preventing effect Effects 0.000 abstract description 7
- 230000004888 barrier function Effects 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 206010053615 Thermal burn Diseases 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 206010042496 Sunburn Diseases 0.000 abstract description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 53
- 239000000686 essence Substances 0.000 description 42
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 230000035755 proliferation Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 6
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000001050 lubricating effect Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010040829 Skin discolouration Diseases 0.000 description 2
- 241000246044 Sophora flavescens Species 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- RCFODGQQTAADES-UHFFFAOYSA-N 3beta-acetoxy-atractylone Natural products CC(=O)OC1C2C(=C)CCCC2(C)Cc3occ(C)c13 RCFODGQQTAADES-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 229940079784 disodium stearoyl glutamate Drugs 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 108010028309 kalinin Proteins 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 229940069764 shark liver oil Drugs 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种幻彩水光肌底精华液及其制备方法，其包括透明质酸钠；戊二醇、甘油聚醚‑26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物；刺阿干树仁油、燕麦β‑葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯以及预先增容的丁二醇和香精。该幻彩水光肌底精华液功效多且佳，不具备调理皮肤、抗衰，保湿、防晒美容养颜的功能。还可起到皮肤的修复治疗作用，可修复皮肤的脂质屏障。在皮肤遭受轻度的烧烫伤时，加速受伤部位皮肤的愈合，可促进受伤部位皮肤的再生，事先使用也有一定预防作用。
Description
技术领域
本发明涉及护肤品领域，具体涉及一种幻彩水光肌底精华液及其制备方法。
背景技术
精华素是用于脸部的护肤品中的一种，含有较珍贵的功效成分，它的作用有防衰老、抗皱、保湿、美白、去斑等等。精华素通常使用在护肤水之后，乳液或面霜之前。目前，缺少一款功效强大，且具备基础一定的皮肤医用修复功能的精华。
发明内容
本发明的目的是提供一种幻彩水光肌底精华液及其制备方法，以解决上述提到的问题。
为解决上述技术问题，本发明提供一种幻彩水光肌底精华液，其包括水、甘油、成份A，组份B和组份C；
其中，成份A包括透明质酸钠；
组份B包括1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物；
组份C包括刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯以及预先增容的丁二醇和香精。
进一步地，精华液中各组分的含量以质量百分比表示为：
甘油1％-5％、透明质酸钠0.2％-2％、1,2-戊二醇1％-4％、甘油聚醚-261％-4％、丙二醇1％-3％、海藻糖0.3％-2％、麦冬根提取物0.3％-2％、扭刺仙人掌茎提取物0.3％-2％、苦参根提取物0.3％-2％；
刺阿干树仁油1％-5％、燕麦β-葡聚糖0.5％-3％、酵母提取物0.5％-3％、膜荚黄芪根提取物0.3％-2％、白术根茎提取物0.2％-2％、防风根提取物0.2％-2％、母菊花提取物0.2％-2％、合欢树皮提取物0.2％-2％、甘草根提取物0.2％-2％、酵母菌/大米发酵产物滤液0.2％-3％、羟苯甲酯0.1％-0.2％、羟苯丙酯0.05％-0.1％以及预先增容的丁二醇2％-8％和香精0.002％。
进一步地，精华液中各组分的含量以质量百分比表示为：
甘油3％、透明质酸钠2％、1,2-戊二醇2％、甘油聚醚-262％、丙二醇1％、海藻糖1.5％、麦冬根提取物2％、扭刺仙人掌茎提取物1.6％、苦参根提取物1.2％；
刺阿干树仁油5％、燕麦β-葡聚糖2％、酵母提取物2％、膜荚黄芪根提取物2％、白术根茎提取物2％、防风根提取物1.8％、母菊花提取物1.6％、合欢树皮提取物1.6％、甘草根提取物1.6％、酵母菌/大米发酵产物滤液2％、羟苯甲酯0.1％、羟苯丙酯0.05％以及预先增容的丁二醇2％、香精0.002％。
进一步地，所述精华液中还包含角鲨烷，且精华液中角鲨烷的含量以质量百分比表示为：角鲨烷1％-5％。
进一步地，所述精华液中还包含组分D，所述组分D包括聚二甲基硅氧烷、异壬酸异壬酯、聚甘油－10硬脂酸酯、聚甘油－2二聚羟基硬脂酸酯、氢化卵磷脂、鲸蜡硬脂醇、硬脂酸、牛油果树果脂、菊粉月桂基氨基甲酸酯、硬脂酰谷氨酸二钠、苯氧乙醇和1，2－己二醇。
进一步地，所述精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％-0.1％、异壬酸异壬酯1％-2％、聚甘油－10硬脂酸酯1％-2％、聚甘油－2二聚羟基硬脂酸酯0.3％-0.5％、氢化卵磷脂1％-2％、鲸蜡硬脂醇0.05％-0.1％、硬脂酸0.01％-0.05％、牛油果树果脂0.2％-2％、菊粉月桂基氨基甲酸酯0.5％-2％、硬脂酰谷氨酸二钠0.01％-0.03％、苯氧乙醇0.05％-0.1％、1，2－己二醇1％-2％。
进一步地，所述精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％、异壬酸异壬酯1％、聚甘油－10硬脂酸酯1％、聚甘油－2二聚羟基硬脂酸酯0.3％、氢化卵磷脂1％、鲸蜡硬脂醇0.1％、硬脂酸0.01％、牛油果树果脂1.8％、菊粉月桂基氨基甲酸酯1％、硬脂酰谷氨酸二钠0.01％、苯氧乙醇0.05％、1，2－己二醇1％。
一种幻彩水光肌底精华液制备方法，其步骤为：将透明质酸钠加入水中搅拌溶解均匀，水为无菌去离子水；将组份B加入溶解有透明质酸钠的水中，进行磁力搅拌，搅拌均匀；将组分C加入溶解有透明质酸钠和组份B的水中，进行磁力搅拌，搅拌均匀，并过滤出料；进行检验、灌装、包装。
进一步地，在将组份B加入溶解有透明质酸钠的水中时，组份B中各成份的加入顺序依次为1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物。
进一步地，在将组分C加入溶解有透明质酸钠和组份B的水中时，组分C中各成份的加入顺序依次为刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯、预先增容好的丁二醇和香精。
本发明的有益效果为：该幻彩水光肌底精华液及其制备方法不仅可重组皮肤的屏障功能，防止肌肤水分过多流失，减少角质层的蜕变，具备调理皮肤的效果，可增强皮肤细胞新陈代谢，有抗衰作用，抗衰、防晒美容养颜的功能。还可起到皮肤的修复治疗作用，可修复皮肤的脂质屏障，对敏感性肌肤又一定的修护效果；可加速表皮细胞的再生，使皮肤细嫩光滑，富有弹性。在皮肤遭受轻度的烧烫伤时，表面涂抹可减轻疼痛，加速受伤部位皮肤的愈合；其通过促进表皮细胞的增殖和分化，以及清除氧自由基的作用，可促进受伤部位皮肤的再生，事先使用也有一定预防作用。
具体实施方式
以下结合实施例进行具体说明。
实施例一
本实施例中给出了一种幻彩水光肌底精华液，具体包括水、甘油、成份A，组份B和组份C；
其中，成份A包括透明质酸钠；
组份B包括1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物。
其中，麦冬根提取物主要来源于麦冬根，富含聚果糖的活性成分，具有较强的抗旱能力，通过加强表皮上层的粘连，重组皮肤的屏障功能，防止肌肤水分过多流失，减少角质层的蜕变，达到保湿效果。
扭刺仙人掌茎提取物具有抗菌性，结合仙人掌提取物对雄性激素受体活性的抑制，可用于粉刺类化妆品，对雄性激素偏高引起的粉刺有防治效果；仙人掌提取物能促进皮肤生长因子的生成，具有活肤的作用，可用于抗衰老化妆品中。
苦参根提取物主要来源于苦参的根部，有效成分主要为苦参碱，是一种传统的草药。用于治疗湿疹和皮炎，具有抗菌消炎的功效；对胶原蛋白生产具有促进作用，对成纤维细胞的增殖也有促进作用，可用作皮肤抗衰老；同时具有保湿的功效。
组份C包括刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯以及预先增容的丁二醇和香精。
其中，本实施例中含有的刺阿干树仁油属于一种坚果油，从摩洛哥坚果树的果实提取而来；其油中含有丰富的脂肪酸、维生素E、角鲨烯和固醇等，可用作治疗皮肤疾病，刺阿干树仁油是重要的化妆品用油脂，能提高良好的滋养性和肤感，对人体有较好的抗氧化能力，以及修复皮肤的脂质屏障，对敏感性肌肤又一定的修护效果。
本实施例中采用的膜荚黄芪根提取物来源于膜荚黄芪的根部，其含有的重要活性成分黄芪皂苷，可刺激皮层细胞的增殖，有调理皮肤的效果。具有抗衰老，预防皱纹的作用。
而白术根茎提取物是菊科苍术属的一种植物，根茎含挥发油，内有α-及β-葎草烯，β-榄香醇，α-姜黄烯，3β-乙酰氧基苍术酮等多种醇类，还含有多种氨基酸。
白术提取物在低浓度时有促进黑色素细胞活性的作用，在高浓度时则为抑制，可分别用于不同制品；白术提取物对层粘连蛋白-5的增殖作用和对胶原蛋白IV型生成的促进，显示该提取物可增强皮肤细胞新陈代谢，有抗衰作用；另可用作化妆品的保湿剂。
防风根提取物含有很多香豆素化合物和色原酮化合物，防风挥发油少量用于配制香精；在试管的脂肪细胞水解试验中，防风提取物对脂肪水解有促进作用，可用于减肥产品；对多种自由基有消除作用，可用作抗氧化剂；对黑色素有一定的抑制作用，可用作美白产品；可以收缩毛孔，用作收敛剂；同时具有抗菌消炎的作用。
母菊花提取物含挥发油、黄酮类化合物、氨基酸、绿原酸和微量元素等。基于菊花提取物具有抗菌、抗氧化、抗炎、舒缓抗敏等生物活性，广泛应用于化妆品中，可起到预防过敏、保湿、防治粉刺和抗衰老等功效。
合欢树皮提取物有显著的抑菌效果，可防止多种体表细菌、真菌感染性疾病，并具有止痒、消炎、去屑等功效，同时，植物甙中含多种氨基酸、维生素A、B族和维生素C、D、E等天然植物营养成分，具有营养肌肤之功效。
甘草根提取物对肌细胞的增殖作用、对血管内皮细胞增殖的促进作用、对胶原蛋白-4型生成的促进，对NO生成的抑制等研究显示，甘草提取物在提高皮肤的活性等方面有促进作用，可用于抗衰化妆品；甘草提取物同时具有抑制黑色素，美白皮肤的作用；对一些细菌具有明显的抑制作用，可用作抗炎剂。
其中，精华液中各组分的含量以质量百分比表示为：甘油1％-5％、透明质酸钠0.2％-2％、1,2-戊二醇1％-4％、甘油聚醚-261％-4％、丙二醇1％-3％、海藻糖0.3％-2％、麦冬根提取物0.3％-2％、扭刺仙人掌茎提取物0.3％-2％、苦参根提取物0.3％-2％；
刺阿干树仁油1％-5％、燕麦β-葡聚糖0.5％-3％、酵母提取物0.5％-3％、膜荚黄芪根提取物0.3％-2％、白术根茎提取物0.2％-2％、防风根提取物0.2％-2％、母菊花提取物0.2％-2％、合欢树皮提取物0.2％-2％、甘草根提取物0.2％-2％、酵母菌/大米发酵产物滤液0.2％-3％、羟苯甲酯0.1％-0.2％、羟苯丙酯0.05％-0.1％以及预先增容的丁二醇2％-8％和香精0.002％。
该幻彩水光肌底精华液通过各成份的配合调剂，可加速表皮细胞的再生，使皮肤细嫩光滑，富有弹性。在皮肤遭受轻度的烧烫伤时，表面涂抹可减轻疼痛，加速受伤部位皮肤的愈合。
该幻彩水光肌底精华液配合各成份，并以透明质酸钠为制备基液，与其他精华液相比，周围环境的相对湿度对其保湿性的影响较小；且在低相对湿度(33％)下的吸湿量最高，而在高相对湿度下的吸湿量最低。
这种独特的性质，正适应皮肤在不同季节，不同环境湿度下，如干燥的冬季和潮湿的夏季，对化妆品保湿作用的要求。
同时，透明质酸钠液是皮肤固有的生物物质，外源性的透明质酸钠是对皮肤内源性ha的补充；mr较小的透明质酸钠可渗入皮肤表皮层，促进皮肤营养的供给和废物的排泄，从而防止皮肤老化，起到美容和养颜作用。
该幻彩水光肌底精华液还具备皮肤损伤的修复和预防作用，皮肤受到阳光暴晒所引起的光灼伤或日炙，如皮肤变红、变黑、脱皮等，主要是阳光中的紫外线的作用。该幻彩水光肌底精华液通过促进表皮细胞的增殖和分化，以及清除氧自由基的作用，可促进受伤部位皮肤的再生，事先使用也有一定预防作用。
但其作用机理与防晒霜中常用的紫外线吸收剂不同，因此，在防晒护肤品中ha与紫外线吸收剂混合使用，具有协同作用，可同时减少紫外线的透过和对透过的少量紫外线所造成的皮肤损伤进行修复，起到双重保护作用。
同时，该幻彩水光肌底精华液还具备润滑性和成膜性，其具有很强的润滑感和成膜性，涂抹时润滑感明显，手感良好。涂于皮肤后，可在皮肤表面形成一层薄膜，使皮肤产生良好的光滑感和湿润感，对皮肤起到保护作用。也可少量用于发部的护理，起到保湿、润滑、护发、消除静电等作用，使头发易于梳理、飘逸自然。
实施例二
本实施例中给出了一种幻彩水光肌底精华液，具体包括水、甘油、成份A，组份B和组份C；
其中，成份A包括透明质酸钠。
组份B包括1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物。
组份C包括刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯以及预先增容的丁二醇和香精。
且精华液中各组分的含量以质量百分比表示为：甘油3％、透明质酸钠2％、1,2-戊二醇2％、甘油聚醚-262％、丙二醇1％、海藻糖1.5％、麦冬根提取物2％、扭刺仙人掌茎提取物1.6％、苦参根提取物1.2％；刺阿干树仁油5％、燕麦β-葡聚糖2％、酵母提取物2％、膜荚黄芪根提取物2％、白术根茎提取物2％、防风根提取物1.8％、母菊花提取物1.6％、合欢树皮提取物1.6％、甘草根提取物1.6％、酵母菌/大米发酵产物滤液2％、羟苯甲酯0.1％、羟苯丙酯0.05％以及预先增容的丁二醇2％、香精0.002％。
实施例三
在上述实施方式的基础上，作为进一步优选地，精华液中还包含角鲨烷，且精华液中的含量以质量百分比表示为：角鲨烷1％-5％。
其角鲨烷的添加可以加速护肤品中的营养成分快速渗透到皮肤深层，角鲨烷也可以抑制皮肤上的霉菌生长，保持肌肤洁净光滑，另外，角鲨烷还有延缓衰老的作用，是一种非常珍贵的护肤品。
角鲨烷是从深海鲨鱼肝脏中提取的一种油脂，又叫做深海鲨鱼肝油，角鲨烷的化学性相较于其他动物油脂来说是比较稳定的，非常亲和皮肤，它副作用也很小。
实施例四
本实施例中给出了一种幻彩水光肌底精华液，在上述实施例的基础上，所述精华液中还包含组分D，所述组分D包括聚二甲基硅氧烷、异壬酸异壬酯、聚甘油－10硬脂酸酯、聚甘油－2二聚羟基硬脂酸酯、氢化卵磷脂、鲸蜡硬脂醇、硬脂酸、牛油果树果脂、菊粉月桂基氨基甲酸酯、硬脂酰谷氨酸二钠、苯氧乙醇和1，2－己二醇。
且精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％-0.1％、异壬酸异壬酯1％-2％、聚甘油－10硬脂酸酯1％-2％、聚甘油－2二聚羟基硬脂酸酯0.3％-0.5％、氢化卵磷脂1％-2％、鲸蜡硬脂醇0.05％-0.1％、硬脂酸0.01％-0.05％、牛油果树果脂0.2％-2％、菊粉月桂基氨基甲酸酯0.5％-2％、硬脂酰谷氨酸二钠0.01％-0.03％、苯氧乙醇0.05％-0.1％、1，2－己二醇1％-2％。
实施例五
在实施例四的基础上，作为进一步优选地，精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％、异壬酸异壬酯1％、聚甘油－10硬脂酸酯1％、聚甘油－2二聚羟基硬脂酸酯0.3％、氢化卵磷脂1％、鲸蜡硬脂醇0.1％、硬脂酸0.01％、牛油果树果脂1.8％、菊粉月桂基氨基甲酸酯1％、硬脂酰谷氨酸二钠0.01％、苯氧乙醇0.05％、1，2－己二醇1％。
实施例六
一种幻彩水光肌底精华液制备方法，其步骤为：将透明质酸钠加入水中搅拌溶解均匀，水为无菌去离子水；将组份B加入溶解有透明质酸钠的水中，进行磁力搅拌，搅拌均匀；将组分C加入溶解有透明质酸钠和组份B的水中，进行磁力搅拌，搅拌均匀，并过滤出料；进行检验、灌装、包装。
当然，在将组份B加入溶解有透明质酸钠的水中时，组份B中各成份的加入顺序依次为1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物。
且，在将组分C加入溶解有透明质酸钠和组份B的水中时，组分C中各成份的加入顺序依次为刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯、预先增容好的丁二醇和香精。
以上所述仅为本发明的优选实施例而已，并不用于限制本发明，对于本领域的技术人员来说，本发明可以有各种更改和变化。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种幻彩水光肌底精华液，其特征在于：包括水、甘油、成份A，组份B和组份C；
其中，成份A包括透明质酸钠；
组份B包括1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物；
组份C包括刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯以及预先增容的丁二醇和香精。
2.根据权利要求1所述的幻彩水光肌底精华液，其特征在于：精华液中各组分的含量以质量百分比表示为：
甘油1％-5％、透明质酸钠0.2％-2％、1,2-戊二醇1％-4％、甘油聚醚-261％-4％、丙二醇1％-3％、海藻糖0.3％-2％、麦冬根提取物0.3％-2％、扭刺仙人掌茎提取物0.3％-2％、苦参根提取物0.3％-2％；
刺阿干树仁油1％-5％、燕麦β-葡聚糖0.5％-3％、酵母提取物0.5％-3％、膜荚黄芪根提取物0.3％-2％、白术根茎提取物0.2％-2％、防风根提取物0.2％-2％、母菊花提取物0.2％-2％、合欢树皮提取物0.2％-2％、甘草根提取物0.2％-2％、酵母菌/大米发酵产物滤液0.2％-3％、羟苯甲酯0.1％-0.2％、羟苯丙酯0.05％-0.1％以及预先增容的丁二醇2％-8％和香精0.002％。
3.根据权利要求1或2所述的幻彩水光肌底精华液，其特征在于：精华液中各组分的含量以质量百分比表示为：
甘油3％、透明质酸钠2％、1,2-戊二醇2％、甘油聚醚-262％、丙二醇1％、海藻糖1.5％、麦冬根提取物2％、扭刺仙人掌茎提取物1.6％、苦参根提取物1.2％；
刺阿干树仁油5％、燕麦β-葡聚糖2％、酵母提取物2％、膜荚黄芪根提取物2％、白术根茎提取物2％、防风根提取物1.8％、母菊花提取物1.6％、合欢树皮提取物1.6％、甘草根提取物1.6％、酵母菌/大米发酵产物滤液2％、羟苯甲酯0.1％、羟苯丙酯0.05％以及预先增容的丁二醇2％、香精0.002％。
4.根据权利要求1所述的幻彩水光肌底精华液，其特征在于，所述精华液中还包含角鲨烷，且精华液中角鲨烷的含量以质量百分比表示为：角鲨烷1％-5％。
5.根据权利要求1所述的幻彩水光肌底精华液，其特征在于：所述精华液中还包含组分D，所述组分D包括聚二甲基硅氧烷、异壬酸异壬酯、聚甘油－10硬脂酸酯、聚甘油－2二聚羟基硬脂酸酯、氢化卵磷脂、鲸蜡硬脂醇、硬脂酸、牛油果树果脂、菊粉月桂基氨基甲酸酯、硬脂酰谷氨酸二钠、苯氧乙醇和1，2－己二醇。
6.根据权利要求5所述的幻彩水光肌底精华液，其特征在于：所述精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％-0.1％、异壬酸异壬酯1％-2％、聚甘油－10硬脂酸酯1％-2％、聚甘油－2二聚羟基硬脂酸酯0.3％-0.5％、氢化卵磷脂1％-2％、鲸蜡硬脂醇0.05％-0.1％、硬脂酸0.01％-0.05％、牛油果树果脂0.2％-2％、菊粉月桂基氨基甲酸酯0.5％-2％、硬脂酰谷氨酸二钠0.01％-0.03％、苯氧乙醇0.05％-0.1％、1，2－己二醇1％-2％。
7.根据权利要求5或6所述的幻彩水光肌底精华液，其特征在于：所述精华液中组分D中各成分的含量以质量百分比表示为：聚二甲基硅氧烷0.05％、异壬酸异壬酯1％、聚甘油－10硬脂酸酯1％、聚甘油－2二聚羟基硬脂酸酯0.3％、氢化卵磷脂1％、鲸蜡硬脂醇0.1％、硬脂酸0.01％、牛油果树果脂1.8％、菊粉月桂基氨基甲酸酯1％、硬脂酰谷氨酸二钠0.01％、苯氧乙醇0.05％、1，2－己二醇1％。
8.一种幻彩水光肌底精华液制备方法，其特征在于，包括如权利要求1～7任一项所述的幻彩水光肌底精华液，所述方法为如下几个步骤：
L1.将透明质酸钠加入水中搅拌溶解均匀，水为无菌去离子水；
L2.将组份B加入溶解有透明质酸钠的水中，进行磁力搅拌，搅拌均匀；
L3.将组分C加入溶解有透明质酸钠和组份B的水中，进行磁力搅拌，搅拌均匀，并过滤出料；
L4.进行检验、灌装、包装。
9.根据权利要求8所述的幻彩水光肌底精华液制备方法，其特征在于：在将组份B加入溶解有透明质酸钠的水中时，组份B中各成份的加入顺序依次为1,2-戊二醇、甘油聚醚-26、丙二醇、海藻糖、麦冬根提取物、扭刺仙人掌茎提取物、苦参根提取物。
10.根据权利要求8所述的幻彩水光肌底精华液制备方法，其特征在于：在将组分C加入溶解有透明质酸钠和组份B的水中时，组分C中各成份的加入顺序依次为刺阿干树仁油、燕麦β-葡聚糖、酵母提取物、膜荚黄芪根提取物、白术根茎提取物、防风根提取物、母菊花提取物、合欢树皮提取物、甘草根提取物、酵母菌/大米发酵产物滤液、羟苯甲酯、羟苯丙酯、预先增容好的丁二醇和香精。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011085102.XA CN112137904A (zh) | 2020-10-12 | 2020-10-12 | 一种幻彩水光肌底精华液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011085102.XA CN112137904A (zh) | 2020-10-12 | 2020-10-12 | 一种幻彩水光肌底精华液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112137904A true CN112137904A (zh) | 2020-12-29 |
Family
ID=73951534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011085102.XA Pending CN112137904A (zh) | 2020-10-12 | 2020-10-12 | 一种幻彩水光肌底精华液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112137904A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113304086A (zh) * | 2021-05-25 | 2021-08-27 | 云南贝泰妮生物科技集团股份有限公司 | 一种多维屏障修复组合物及其制备方法 |
| CN113876683A (zh) * | 2021-10-15 | 2022-01-04 | 深圳美芙美学健康咨询有限公司 | 燕窝植物复合柔肤水 |
| CN115645321A (zh) * | 2022-09-29 | 2023-01-31 | 广州香乐谷生物科技有限公司 | 一种精华液、应用及制备方法和精华液产品 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687109A (zh) * | 2016-03-09 | 2016-06-22 | 广州千百度化妆品有限公司 | 一种祛痘修复精华 |
| CN107648101A (zh) * | 2017-10-09 | 2018-02-02 | 无比滴（广东）药业有限公司 | 一种具有温热功效的外用组合物及其制备方法 |
| CN108354863A (zh) * | 2018-03-31 | 2018-08-03 | 佛山文森特知识产权服务有限公司 | 一种舒敏修复组合物 |
| CN110339131A (zh) * | 2019-08-15 | 2019-10-18 | 广东芭薇生物科技股份有限公司 | 一种修护乳及其制备方法 |
| CN110652489A (zh) * | 2019-09-06 | 2020-01-07 | 奢脉国际化妆品(北京)有限公司 | 一种具有舒敏修复功效的多肽精华液及其制备方法 |
| CN111568823A (zh) * | 2020-04-17 | 2020-08-25 | 安婕妤化妆品科技股份有限公司 | 一种紧致肌肤、抗初老的精华液及其制备方法 |
-
2020
- 2020-10-12 CN CN202011085102.XA patent/CN112137904A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687109A (zh) * | 2016-03-09 | 2016-06-22 | 广州千百度化妆品有限公司 | 一种祛痘修复精华 |
| CN107648101A (zh) * | 2017-10-09 | 2018-02-02 | 无比滴（广东）药业有限公司 | 一种具有温热功效的外用组合物及其制备方法 |
| CN108354863A (zh) * | 2018-03-31 | 2018-08-03 | 佛山文森特知识产权服务有限公司 | 一种舒敏修复组合物 |
| CN110339131A (zh) * | 2019-08-15 | 2019-10-18 | 广东芭薇生物科技股份有限公司 | 一种修护乳及其制备方法 |
| CN110652489A (zh) * | 2019-09-06 | 2020-01-07 | 奢脉国际化妆品(北京)有限公司 | 一种具有舒敏修复功效的多肽精华液及其制备方法 |
| CN111568823A (zh) * | 2020-04-17 | 2020-08-25 | 安婕妤化妆品科技股份有限公司 | 一种紧致肌肤、抗初老的精华液及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 武谦虎: "《美容食物一本通》", 31 October 2013, 中国医药科技出版社 * |
| 马振友等: "《皮肤美容化妆品制剂手册》", 31 March 2004, 中医古籍出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113304086A (zh) * | 2021-05-25 | 2021-08-27 | 云南贝泰妮生物科技集团股份有限公司 | 一种多维屏障修复组合物及其制备方法 |
| CN113876683A (zh) * | 2021-10-15 | 2022-01-04 | 深圳美芙美学健康咨询有限公司 | 燕窝植物复合柔肤水 |
| CN115645321A (zh) * | 2022-09-29 | 2023-01-31 | 广州香乐谷生物科技有限公司 | 一种精华液、应用及制备方法和精华液产品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103237555B (zh) | 外用皮肤护理制剂 | |
| KR101509608B1 (ko) | 두피 및 모발 상태 개선용 조성물 | |
| CA2277213C (en) | Cosmetic formulations containing extracts from phyllantus emblica and centella asiatica and/or bacopa monnieri | |
| CN109453087B (zh) | 美白透肌水及其制备方法和美白化妆品添加剂 | |
| CN105748354A (zh) | 一种面膜液及其制备方法 | |
| CN112137904A (zh) | 一种幻彩水光肌底精华液及其制备方法 | |
| KR100960054B1 (ko) | 탈모방지 및 두피개선을 위한 두발 화장품 조성물 | |
| CN109662928A (zh) | 一种具有防晒修复功效的护肤组合物及其应用和制备方法 | |
| CN110664650A (zh) | 多效护肤组合物和精华液及其制备方法 | |
| CN109106677B (zh) | 一种具有美白功能的组合物及其应用 | |
| CN109350579B (zh) | 美白化妆品添加剂和美白醒肤露及其制备方法 | |
| CN109453059B (zh) | 美白化妆品添加剂和美白睡眠面膜及其制备方法 | |
| CN103356425B (zh) | 剥离型人参面膜及其制备方法 | |
| CN109330954B (zh) | 美白亮肤水及其制备方法和酪氨酸酶抑制剂 | |
| CN112043661B (zh) | 一种美白芦荟胶及其制备方法 | |
| CN110420150A (zh) | 一种含有辣木籽提取物的抗衰老护肤品组合物 | |
| CN111939117A (zh) | 一种倍润修护元气霜及其制备工艺 | |
| CN110721148A (zh) | 一种多方位提拉紧致多肽精华液及其制备方法 | |
| CN113908092B (zh) | 一种肌肤祛痘、控油可溶美容微针贴膜组合物及其制备方法 | |
| KR101749690B1 (ko) | 배초향을 함유하는 피지관리 및 모공개선 화장료 조성물 | |
| CN111973501A (zh) | 一种神经酰胺赋活乳及其制备方法 | |
| CN105232393A (zh) | 一种具有经典活血祛斑抗皱养颜功效的美容组合物及其应用 | |
| CN111973486A (zh) | 一种神经酰胺滋润保湿霜及其制备方法 | |
| CN109568207B (zh) | 美白化妆品添加剂和美白补水面膜及其制备方法 | |
| KR101948597B1 (ko) | 세정력 및 두피 진정효과가 우수한 모발용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |
|
| RJ01 | Rejection of invention patent application after publication |